Clinical Trial Update: A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for MBQ-167 in participants with advanced breast cancer, currently recruiting to evaluate safety and dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• MBQ-167 (MBQ-167)

Snippet

Sponsor: MBQ Pharma | Conditions: Breast Cancer, Breast Neoplasm | Phase 1 | Status: RECRUITING